Contact
Please use this form to send email to PR contact of this press release:
Targovax announces that first combination trials with ONCOS-102 have passed their initial, planned, independent safety reviews
TO:
Please use this form to send email to PR contact of this press release:
Targovax announces that first combination trials with ONCOS-102 have passed their initial, planned, independent safety reviews
TO: